Unitree Clears Shanghai IPO Hurdle, Targets $621M Raise
Key insights
- Unitree's listing committee clearance advances its plan to raise 4.2 billion yuan ($621 million) on the Star Market by selling at least 40.4 million shares.
- Despite trailing UBTech's 2 billion yuan in revenue, Unitree's 590.8 million yuan net profit is the highest among competing humanoid robot firms.
- Dobot, Leju Robotics, and Deep Robotics are all pursuing concurrent IPO filings alongside Unitree in China's humanoid robot sector.
Why this matters
The listing committee clearance is the critical exchange-level gate before further regulatory approval, making Unitree's advancement substantively different from merely filing an application, and it occurs while multiple competitors are simultaneously in the IPO pipeline. Morgan Stanley's framing of a "humanoid IPO wave" signals that public market capital flows, not just venture funding, are about to reshape R&D budgets and competitive dynamics across the humanoid robotics sector. For technical leaders and founders tracking the space, Unitree's Star Market listing will establish a market-tested valuation for a leading humanoid robot company, creating a pricing reference point that will influence how robotics startups globally are assessed by investors.
Summary
Unitree Robotics passed a Shanghai Stock Exchange listing committee hearing on Monday, clearing the critical exchange-level checkpoint on its path to a Star Market IPO. The Hangzhou-based company filed for listing on March 20 and is targeting 4.2 billion yuan ($621 million) through the sale of at least 40.4 million shares, representing a minimum 10 percent ownership stake.
Unitree posted 1.7 billion yuan in revenue last year alongside 590.8 million yuan in net profit, the highest among its direct competitors, though it still trails UBTech's 2 billion yuan in revenue. Profitability is the company's sharpest differentiator heading into a crowded public-markets window.
Essentially: (Unitree, Dobot, Leju Robotics, Deep Robotics) are all advancing toward Chinese public listings simultaneously, compressing what was a private-capital sector into a public equity race.
- Unitree's 590.8 million yuan net profit leads the competitive field despite ranking second to UBTech on revenue.
- Dobot is pursuing a dual listing; Leju Robotics and Deep Robotics are targeting Shenzhen and Shanghai respectively.
- Morgan Stanley research leadership: "The humanoid IPO wave will raise market interest in robotics equities."
China's humanoid robot sector is shifting from venture capital into public equity, with multiple firms converging on exchanges at the same time.
Potential risks and opportunities
Risks
- With Dobot, Leju Robotics, and Deep Robotics all pursuing IPOs concurrently, STAR Market investor appetite could be spread thin, compressing Unitree's opening valuation even after listing committee clearance.
- Unitree trails UBTech in revenue (1.7 billion yuan versus 2 billion yuan); if UBTech moves aggressively toward its own listing, it could draw institutional capital that would otherwise anchor the Unitree raise.
- Morgan Stanley's predicted market interest in robotics equities depends on sustained sector momentum; near-term commercial disappointment in humanoid robot deployment could trigger post-IPO selling pressure across all newly listed Chinese robotics companies simultaneously.
Opportunities
- Investment banks advising on the concurrent humanoid robot IPO pipeline -- covering Unitree, Dobot, Leju Robotics, and Deep Robotics -- stand to capture significant underwriting and advisory fees across multiple transactions in a compressed window.
- Institutional investors seeking liquid humanoid robot exposure can use Unitree's STAR Market listing as a proxy vehicle before comparable Western robotics companies reach public-market stages.
- Unitree's high net profit margin (590.8 million yuan on 1.7 billion yuan in revenue) creates a favorable story for index inclusion and passive fund inflows post-listing, benefiting early shareholders seeking an exit at a public market premium.
What we don't know yet
- The article does not specify Unitree's implied market capitalization at IPO -- only the raise amount and minimum stake percentage -- leaving the full listing valuation undisclosed.
- No timeline is provided for the follow-on regulatory approvals needed after the exchange committee clearance, so the actual trading start date remains unknown.
- Whether Unitree's revenue breakdown between humanoid robots and its quadruped robot products will be disclosed in detail before the IPO closes is not addressed in the article.
Originally reported by scmp.com
Read the original article →Original headline: Unitree Clears Key Hurdle to Shanghai IPO as China's Humanoid Robot Wave Gathers Pace